Furman WL - Search Results

1

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children.

Furman WL, Stewart CF, Poquette CA, Pratt CB, Santana VM, Zamboni WC, Bowman LC, Ma MK, Hoffer FA, Meyer WH, Pappo AS, Walter AW, Houghton PJ. Furman WL, et al. J Clin Oncol. 1999 Jun;17(6):1815-24. doi: 10.1200/JCO.1999.17.6.1815. J Clin Oncol. 1999. PMID: 10561220 Clinical Trial.

2

Use of GM-CSF in children after high-dose chemotherapy.

Furman WL, Fairclough D, Cain AM, Arnold BA, Pratt CB, Meyer WH, Crist WM. Furman WL, et al. Med Pediatr Oncol Suppl. 1992;2:26-30. doi: 10.1002/mpo.2950200707. Med Pediatr Oncol Suppl. 1992. PMID: 1306884

3

Recombinant human TNF-alpha stimulates the secretion of granulocyte colony-stimulating factor in vivo.

Furman WL, Lumm W, Arnold B, Pratt CB, Ihle JN. Furman WL, et al. Leukemia. 1992 Apr;6(4):319-22. Leukemia. 1992. PMID: 1375304

4

Update of St Jude Study XI for childhood acute lymphoblastic leukemia.

Rivera GK, Pui CH, Hancock ML, Mahmoud H, Santana V, Sandlund JT, Hurwitz C, Ribeiro R, Furman W, Crist WM. Rivera GK, et al. Leukemia. 1992;6 Suppl 2:153-6. Leukemia. 1992. PMID: 1578920

5

Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988.

Bowman LC, Hancock ML, Santana VM, Hayes FA, Kun L, Parham DM, Furman WL, Rao BN, Green AA, Crist WM. Bowman LC, et al. Among authors: furman wl. J Clin Oncol. 1991 Sep;9(9):1599-608. doi: 10.1200/JCO.1991.9.9.1599. J Clin Oncol. 1991. PMID: 1831494

6

Staging systems in neuroblastoma: which is best?

Bowman LC, Santana VM, Green AA, Furman WL, Hancock ML, Crist WM. Bowman LC, et al. Among authors: furman wl. J Clin Oncol. 1991 Jan;9(1):189-91. doi: 10.1200/JCO.1991.9.1.189. J Clin Oncol. 1991. PMID: 1985168 No abstract available.

7

Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.

Furman WL, Fairclough DL, Huhn RD, Pratt CB, Stute N, Petros WP, Evans WE, Bowman LC, Douglass EC, Santana VM, et al. Furman WL, et al. J Clin Oncol. 1991 Jun;9(6):1022-8. doi: 10.1200/JCO.1991.9.6.1022. J Clin Oncol. 1991. PMID: 2033415

8

Current approaches to therapy for childhood lymphoblastic leukemia: St. Jude studies XI (1984-1988) and XII (1988).

Rivera GK, Kalwinsky DK, Rodman J, Kun L, Mirro J, Pui CH, Abromowitch M, Ochs J, Furman W, Santana VM, et al. Rivera GK, et al. Haematol Blood Transfus. 1989;32:58-64. doi: 10.1007/978-3-642-74621-5_8. Haematol Blood Transfus. 1989. PMID: 2625263 No abstract available.

9

Mortality in pediatric phase I clinical trials.

Furman WL, Pratt CB, Rivera GK, Krischer JP, Kamen BA, Vietti TJ. Furman WL, et al. J Natl Cancer Inst. 1989 Aug 2;81(15):1193-4. doi: 10.1093/jnci/81.15.1193. J Natl Cancer Inst. 1989. PMID: 2746673 No abstract available.

10

Primary lymphoma of bone in children.

Furman WL, Fitch S, Hustu HO, Callihan T, Murphy SB. Furman WL, et al. J Clin Oncol. 1989 Sep;7(9):1275-80. doi: 10.1200/JCO.1989.7.9.1275. J Clin Oncol. 1989. PMID: 2769328

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page